Europe’s immuno-oncology pipeline has a translation problem. Can SITC’s Lausanne summit fix it?
SITC’s Lausanne summit will connect regulators, biotech and academia to sharpen Europe’s path from immuno-oncology science to clinical trials.
Pharma & Biotech
Pharma & Biotech
Why Norgine’s PEDMARQSI approval in Switzerland could reshape cisplatin ototoxicity management
Swissmedic approved PEDMARQSI for cisplatin-related hearing loss in children. Read why this could reshape paediatric oncology supportive care.
Pharma & Biotech
What does Swissmedic approval of Santhera’s AGAMREE mean for long-term steroid treatment in Duchenne muscular dystrophy?
Swissmedic approves Santhera’s AGAMREE for Duchenne muscular dystrophy. Find out how vamorolone could reshape long-term steroid treatment strategies.